COST BENEFIT STUDIES ON THE CONTROL OF MIXED ENTERIC INFECTIONS AND PROLIFERATIVE ENTEROPATHY IN ASIA
Brachyspira/Lawsonia mixed enteric infections Proliferative Enteropathy performance parameters cost benefit evaluation.
U.Klein P.Poolperm M.Shimaoka
Novartis Animal Health Inc.,Basel Switzerland Swine Medicine Group, Kasetsart University Thailand Shokukanken Inc., Gunma Japan
国际会议
亚洲猪病学会第三届学术会议(Proceedings the 3rd Congress of the Asian Pig Veterinary Society)
武汉
英文
42
2007-04-22(万方平台首次上网日期,不代表论文的发表时间)